Pitavastatin Calcium Patent Expiration
Pitavastatin Calcium is Used for improving lipid profiles in patients with hyperlipidemia or mixed dyslipidemia. It was first introduced by Kowa Co Ltd
Pitavastatin Calcium Patents
Given below is the list of patents protecting Pitavastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Livalo |
US7022713 (Pediatric) | Hyperlipemia therapeutic agent |
Aug 19, 2024
(Expired) | Kowa Co |
| Livalo |
US8557993 (Pediatric) | Crystalline forms of pitavastatin calcium |
Aug 02, 2024
(Expired) | Kowa Co |
| Livalo | US7022713 | Hyperlipemia therapeutic agent |
Feb 19, 2024
(Expired) | Kowa Co |
| Livalo | US8557993 | Crystalline forms of pitavastatin calcium |
Feb 02, 2024
(Expired) | Kowa Co |
| Livalo |
US5856336 (Pediatric) | Quinoline type mevalonolactones |
Jun 25, 2021
(Expired) | Kowa Co |
| Livalo | US5856336 | Quinoline type mevalonolactones |
Jan 01, 2021
(Expired) | Kowa Co |
| Livalo | US6465477 | Stable pharmaceutical composition |
Dec 20, 2016
(Expired) | Kowa Co |
| Livalo | US5854259 | Quinoline type mevalonolactones |
Dec 29, 2015
(Expired) | Kowa Co |
| Livalo | US5753675 | Quinoline analogs of mevalonolactone and derivatives thereof |
May 19, 2015
(Expired) | Kowa Co |
Pitavastatin Calcium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List